Mr. Suwat Eiewaksorn Mr. Suwat Eiewaksorn conspired with other alleged persons to operate derivatives broker businesses in Thailand without proper licenses granted. Such action was deemed a violation
ก.ล.ต. ร่วมกับตลาดหลักทรัพย์แห่งประเทศไทย (ตลท.) จัดงานสัมมนา ?การดำเนินคดีแบบกลุ่ม? หรือ class action ให้ผู้เกี่ยวข้องในตลาดทุนทราบถึงสาระสำคัญและกระบวนการที่เกี่ยวข้อง บรรยายโดย นายพงษ์เดช วานิช
persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator
, including transfer of related brand names from the selling shareholder(s). According to the Notification of the Capital Market Supervisory Board No. TorChor. 20/2551 Re: Rules on Entering into Material
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
DEAN & DELUCA of 2,434 million Baht (28% of total revenue), a decrease of 708 million Baht or 23% as compared to 2017 and (3) other income including trademark and trade name fees of DEAN & DELUCA of 264
DEAN & DELUCA of 2,434 million Baht (28% of total revenue), a decrease of 708 million Baht or 23% as compared to 2017 and (3) other income including trademark and trade name fees of DEAN & DELUCA of 264
acquisition was 2,396 million Baht. Also, the intangible assets arising from DEAN&DELUCA’s business; for example, trademark, trade name, copyrights, etc. of the DEAN&DELUCA brand were 1,819 million Baht. The
to 2Q 2018 of 568 million Baht, (2) other income including trademark and trade name fees of DEAN & DELUCA of 12.34 million Baht (3% of total revenue); significantly decreased by 49% as compared to 2Q
. Also, the intangible assets arising from Dean & DeLuca’s business; for example, trademark, trade name, copyrights, etc. of the Dean & DeLuca brand were 1,719 million Baht. The main assets were 82% of the